Search research articles
Contact Us
Filters
Showing results (1-10 of 12) with videos related to
Page
of 2
Sort By:
Scientific Reports
|
February 11, 2022
Exploring synthetic biology for the development of a sensor cell line for automated bioprocess control
Nikolas Zeh, Melina Bräuer, Nadja Raab, et al.
Metabolic Engineering Communications
|
August 17, 2021
Cell line development for continuous high cell density biomanufacturing: Exploiting hypoxia for improved productivity
Nikolas Zeh, Patrick Schlossbauer, Nadja Raab, et al.
Applied Microbiology and Biotechnology
|
August 29, 2022
Life at the periphery: what makes CHO cells survival talents
Tobias Jerabek, Florian Klingler, Nadja Raab, et al.
Molecular & Cellular Proteomics : MCP
|
August 7, 2022
Spatial Proteomics Reveals Differences in the Cellular Architecture of Antibody-Producing CHO and Plasma Cell-Derived Cells
Robin Kretz, Larissa Walter, Nadja Raab, et al.
New Biotechnology
|
December 28, 2023
In pursuit of a minimal CHO genome: Establishment of large-scale genome deletions
Tobias Jerabek, Linus Weiß, Hannah Fahrion, et al.
Biotechnology Journal
|
February 26, 2019
CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines
Nadja Raab, Sven Mathias, Kerstin Alt, et al.
Metabolic Engineering
|
April 1, 2024
Nature as blueprint: Global phenotype engineering of CHO production cells based on a multi-omics comparison with plasma cells
Nadja Raab, Nikolas Zeh, Robin Kretz, et al.
Biotechnology and Bioengineering
|
May 5, 2021
Unveiling the CHO surfaceome: Identification of cell surface proteins reveals cell aggregation-relevant mechanisms
Florian Klingler, Sven Mathias, Helga Schneider, et al.
Biotechnology and Bioengineering
|
October 22, 2019
Unraveling what makes a monoclonal antibody difficult-to-express: From intracellular accumulation to incomplete folding and degradation via ERAD
Sven Mathias, Anna Wippermann, Nadja Raab, et al.
New Biotechnology
|
October 28, 2021
A blueprint from nature: miRNome comparison of plasma cells and CHO cells to optimize therapeutic antibody production
Nadja Raab, Nikolas Zeh, Patrick Schlossbauer, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 12) with videos related to
Sort By:
Page
of 2
Scientific Reports
|
February 11, 2022
Exploring synthetic biology for the development of a sensor cell line for automated bioprocess control
Nikolas Zeh, Melina Bräuer, Nadja Raab, et al.
Metabolic Engineering Communications
|
August 17, 2021
Cell line development for continuous high cell density biomanufacturing: Exploiting hypoxia for improved productivity
Nikolas Zeh, Patrick Schlossbauer, Nadja Raab, et al.
Applied Microbiology and Biotechnology
|
August 29, 2022
Life at the periphery: what makes CHO cells survival talents
Tobias Jerabek, Florian Klingler, Nadja Raab, et al.
Molecular & Cellular Proteomics : MCP
|
August 7, 2022
Spatial Proteomics Reveals Differences in the Cellular Architecture of Antibody-Producing CHO and Plasma Cell-Derived Cells
Robin Kretz, Larissa Walter, Nadja Raab, et al.
New Biotechnology
|
December 28, 2023
In pursuit of a minimal CHO genome: Establishment of large-scale genome deletions
Tobias Jerabek, Linus Weiß, Hannah Fahrion, et al.
Biotechnology Journal
|
February 26, 2019
CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines
Nadja Raab, Sven Mathias, Kerstin Alt, et al.
Metabolic Engineering
|
April 1, 2024
Nature as blueprint: Global phenotype engineering of CHO production cells based on a multi-omics comparison with plasma cells
Nadja Raab, Nikolas Zeh, Robin Kretz, et al.
Biotechnology and Bioengineering
|
May 5, 2021
Unveiling the CHO surfaceome: Identification of cell surface proteins reveals cell aggregation-relevant mechanisms
Florian Klingler, Sven Mathias, Helga Schneider, et al.
Biotechnology and Bioengineering
|
October 22, 2019
Unraveling what makes a monoclonal antibody difficult-to-express: From intracellular accumulation to incomplete folding and degradation via ERAD
Sven Mathias, Anna Wippermann, Nadja Raab, et al.
New Biotechnology
|
October 28, 2021
A blueprint from nature: miRNome comparison of plasma cells and CHO cells to optimize therapeutic antibody production
Nadja Raab, Nikolas Zeh, Patrick Schlossbauer, et al.
Page
of 2